Tagged with EALTH

Pharma Having led a successful turnaround of the affiliate in just eight months, Nadia Cortesi of ResMed explains how she has achieved double digit growth, while facing sustained external challenges, including low awareness among consumers and healthcare authorities of the potential complications that sleep pathologies can cause. Can you please introduce…

Pharma Despite the already existing efficiencies in the Italian healthcare system, there is still significant room for improvement. Johnson & Johnson Medical’s head for southern Europe discusses a number of opportunities where the company can help to improve healthcare quality while reducing costs holistically. Given Italy’s current healthcare sustainability concerns, what…

Pharma 3PL player BOMI Group went public via an IPO in June 2015. VP & CFO Marco Ruini discusses the reasons behind this Italian family company’s decision to go public, as well as its ambitious expansion strategy. How would you assess the success of the IPO that took place last year? This IPO…

Pharma Veronika Ferencz, Sales and Marketing Director for Exeltis Hungary, discusses the evolving and expanding footprint of the company in Hungary, the challenges strict regulations on food supplements are causing, as well as the need for better recognition of women’s health as a therapeutic area. She also reflects on her own…

Pharma The leadership of Meditop discuss their history as the first non-privatized, private Hungarian pharmaceutical company, their ongoing strategies for growth in the country, and their evolving portfolio abroad. They also discuss the complexities of the Hungarian healthcare and pharmaceutical market and give an overview of their past challenges and current…

Pharma KPMG is committed to providing long-term support to public as well as private institutions as they tackle challenges and transform the way healthcare is provided. Alberto De Negri, partner of the healthcare practice, discusses his perspective about the Italian healthcare system and the challenges it is currently facing. What have…

Pharma The CEO of CzechInvest elaborates on the significance of the healthcare and life science industry for the Czech Republic’s transition into an industry 4.0. Furthermore, he reviews what the Czech Republic has to offer for foreign investors over its regional neighbors. Before assuming the position of CEO at CzechInvest you…

Pharma As an emerging leader in mobile health and provider of innovative health-technologies, Philips is poised to provide Italian healthcare institutions with solutions that could enable significant gains in efficiency. CEO of the Italian affiliate Stefano Folli discusses the healthcare sustainability challenges facing Italy, and explains how Philips technologies will be…

Pharma Roland Berger’s Patrick Biecheler discusses the French healthcare system, their role in offering specialized consultancy services to the pharmaceutical sector, and the digitalization of the healthcare industry.  Can you please start by giving us a brief overview of Roland Berger’s “Healthcare Competence Centre”, the rationale behind basing it in France,…

Pharma A physician sending off a quick update to a patient via smartphone; a medical caretaker receiving an alert message that a patient’s medical device requires immediate attention. These are no longer hypothetical ideas of healthcare in the distant future, but very real innovations currently being rolled out and integrated across…

Pharma AmCham Hungary, one of the largest American Chambers of Commerce in Central and Eastern Europe, discusses their advocacy efforts, particularly highlighting the chamber’s recently established Healthy Nation Policy Task Force and its aim to positively shape the current and future state of healthcare in Hungary. Can you please describe for…

Pharma Lyonbiopole was established in 2005 as a cluster designed to support the local business community focused on infectious diseases and microbiology. Philippe Archinard, the Biopole’s president, traces the evolution of the cluster over the last decade while underscoring the critical importance of transparency and collaboration between government, industry and academia.…